Roivant Sciences (NASDAQ:ROIV) just reported results for the fourth quarter of 2024.
- Roivant Sciences reported earnings per share of -19 cents. This was above the analyst estimate for EPS of -30 cents.
- The company reported revenue of $28.93 million.
- This was 9.88% worse than the analyst estimate for revenue of $32.10 million.